GAM Systematic’s Medidata Solutions, Inc. MDSO Stock Holding History

GAM Systematic’s Portfolio MDSO Stock Details MDSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-629	Closed	-$49K	–	644
2017 Q2	$49K	Buy	+629	New	+$43.8K	0.01%	555

Other funds holding MDSO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

GAM Systematic's MDSO Position: Q3 2017 in Review

GAM Systematic sold out of Medidata Solutions, Inc. (MDSO) in Q3 2017, closing a stake of 629 shares — an estimated $49K sold.

GAM Systematic first reported a position in MDSO in Q2 2017 and held it in 1 quarter. The position peaked at $49K in Q2 2017. 249 funds tracked by Wall St. Rank hold MDSO as of Q3 2017.

GAM Systematic reported no remaining Medidata Solutions, Inc. position as of Q3 2017 after selling out during the quarter.
GAM Systematic sold 629 Medidata Solutions, Inc. shares in Q3 2017, an estimated $49K.
GAM Systematic first reported a position in Medidata Solutions, Inc. in Q2 2017 and held it in 1 quarter.
GAM Systematic's Medidata Solutions, Inc. position peaked at $49K in Q2 2017.
249 funds tracked by Wall St. Rank held Medidata Solutions, Inc. as of Q3 2017.

Based on GAM Systematic's 13F filing for Q3 2017, filed 14 Nov 2017.